FDA starts review of Roche’s multiple sclerosis pill

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 30 Sept, 15:54 UTC

The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.

science

Sources

• T2FDA starts review of Roche’s multiple sclerosis pillBioPharma Dive / Healthcare Dive / MedTech Dive30 Sept, 15:54